Alterity Therapeutics to Host Webcast Today on New Data from the bioMUSE Natural History Study – Bio Tech Winners
Reader Interactions
This site uses Akismet to reduce spam. Learn how your comment data is processed.
Similar Posts
Double Your Money? Top 2 Canadian Stocks in a Tariff-Sensitive Market
Tariffs are unwelcome in financial markets and disliked by investors. These duties disrupt trade, alter the investment landscape, and heighten volatility. Fortunately, not all sectors have incurred losses due to tariff chaos. Canada’s main stock index advanced nearly 7.2% in the last three months, notwithstanding the U.S.-initiated trade war. As of June 4, 2025, 8…
Gold Doesn’t Need Bad News—It Needs Real News (NFP Post-Mortem)
Gold isn’t just a trade; it’s insurance. And in 2026, that insurance is being aggressively re-priced. The recent U.S. jobs data quietly signaled a shift that manual and algo-traders alike cannot ignore: the labor market is losing its structural momentum, but wage-push inflation is staying “sticky.” This is the ultimate gasoline for XAUUSD. The Hard…
Dixon Tech, Titan among top 10 consumer durable gainers as sector outperforms in a shaky week – Durable Gainers
Indian markets ended slightly lower amid global jitters, but consumer durables outperformed. Dixon Technologies, Titan, and Kalyan Jewellers led sector gains, showcasing resilience amid uncertainty. Source link
Capital Infra Trust InvIT IPO GMP Today: Lot Size & Price
January 3, 2025January 3, 2025 Introduction to Capital Infra Trust InvIT IPO Capital Infra Trust Invit is rolling out an IPO for 1578 cr. The application for the IPO will start from 7th to 9th of January. The Capital Infra IPO consists of ₹1077 Cr fresh issue and ₹501…
